跳至主要内容
临床试验/NCT00432757
NCT00432757已完成3 期

A Multi-Center, Randomized, Double-Masked, Placebo-Controlled Evaluation of the Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens as Compared to Placebo in the Prevention of Allergic Conjunctivitis in a Population of Allergic Contact Lens Wearers

Vistakon Pharmaceuticals3 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2007年1月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
120
试验地点
3
主要终点
Ocular itching

研究概览

简要总结

The purpose of this study is to evaluate the efficacy and safety of an anti-allergy drug with a contact lens compared to placebo in preventing ocular itching associated with allergic conjunctivitis

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
8 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • history of ocular allergies and a positive skin test reaction to cat hair, cat dander, grasses, ragweed, and/or trees within the past 24 months; successful soft contact lens wearer who has frequently worn contact lenses for at least one month or more

排除标准

  • active ocular infection; clinically significant blepharitis; follicular conjunctivitis; pterygium; narrow angle glaucoma; dry eye syndrome; ocular surgery within past 6 months; pregnancy or lactation

结局指标

主要结局

Ocular itching

次要结局

  • Conjunctival, ciliary, and episcleral redness; chemosis and mucous discharge; tearing and lid swelling

研究者

发起方
Vistakon Pharmaceuticals
申办方类型
Industry

研究点 (3)

Loading locations...

相似试验